178215-45-7 Usage
General Description
ALLYL 4-BROMOBUTYRATE is a chemical compound with the molecular formula C7H11BrO2. It is a colorless to pale yellow liquid with a pungent odor. This chemical is primarily used as a flavoring agent and fragrance ingredient in the food and cosmetic industries. It is also used in the production of pharmaceuticals and as a chemical intermediate in organic synthesis. Allyl 4-bromobutyrate is known to be a skin and eye irritant, and prolonged or repeated exposure may cause respiratory irritation. It is important to handle and use this chemical with caution and proper protective equipment to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 178215-45-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,2,1 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 178215-45:
(8*1)+(7*7)+(6*8)+(5*2)+(4*1)+(3*5)+(2*4)+(1*5)=147
147 % 10 = 7
So 178215-45-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H11BrO2/c1-2-6-10-7(9)4-3-5-8/h2H,1,3-6H2
178215-45-7Relevant articles and documents
PD-1/PD-L1 INHIBITORS
-
Page/Page column 328, (2018/11/22)
Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Azetidinone derivatives for the treatment of atherosclerosis
-
, (2008/06/13)
PCT No. PCT/EP95/04202 Sec. 371 Date Sep. 30, 1997 Sec. 102(e) Date Sep. 30, 1997 PCT Filed Oct. 25, 1995 PCT Pub. No. WO96/13484 PCT Pub. Date May 9, 1996Azetidinone derivatives of formula (I) in which R1 and R2, which may be the same or different, is each selected from hydrogen or C(1-8)alkyl; R3 is C(1-8)alkyl or C(3-8)cycloalkyl each of which may be optionally substituted; X is a linker group; Y is an aryl group; and n is 0, 1 or 2; and excluding benzyl (4-methylthio-2-oxo-azetidin-1-yl)acetate are inhibitors of the enzyme Lp PLA2 and are of use in therapy, in particular treating atherosclerosis.
